Tom Dreisbach
Tom Dreisbach is a correspondent on NPR's Investigations team focusing on breaking news stories.
His reporting on issues like COVID-19 scams and immigration detention has sparked federal investigations and has been cited by members of congress. Earlier, Dreisbach was a producer and editor for NPR's Embedded, where his work examined how opioids helped cause an HIV outbreak in Indiana, the role of video evidence in police shootings and the controversial development of Donald Trump's Southern California golf club. In 2018, he was awarded a national Edward R. Murrow Award from RTDNA. Prior to Embedded, Dreisbach was an editor for All Things Considered, NPR's flagship afternoon news show.
-
The New York Times reported that President Trump deducted more than $70,000 in expenses related to hairstyling while he was on The Apprentice. NPR discusses whether doing so is legal.
-
Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company. -
Postmaster General Louis DeJoy, a longtime Republican donor, controls the U.S. Postal Service at a time when mail-in voting is central to the presidential election. -
Kodak and Sen. Richard Burr, R-N.C., are facing high-profile insider trading investigations, but data show the Securities and Exchange Commission pursued far fewer insider trading cases last year.
-
Federal law generally prohibits dietary supplements from claiming to treat specific diseases or viruses. Yet NPR found more than 100 products sold on Amazon that make unsubstantiated antiviral claims. -
When Lauren Jenkins learned a coworker had tested positive for the coronavirus, she did what once would've seemed unthinkable — separating from her two young boys and a husband with stage IV cancer. -
The Los Angeles city attorney reached a settlement with RootMD over sales of "at-home Covid-19 exposure and immunity tests." The city attorney alleged RootMD violated food and drug regulations. -
The leaders of the Securities and Exchange Commission's enforcement division say they are taking aggressive action to combat potential investment fraud related to the COVID-19 pandemic. -
The Food and Drug Administration says it has not authorized any at-home tests for the coronavirus. After one company started selling an at-home test in March, the city attorney of Los Angeles sued. -
The Wellness Matrix Group has offered customers an "at-home kit" for coronavirus testing that is "FDA Approved." But the agency has not approved any such tests, and customers say they feel scammed.